A new manufacturing facility has officially opened its doors in Charlottesville, VA, dedicated to the production of tagatose, a sweet plant-based material with numerous health benefits. The facility, owned and operated by Bonumose, will produce high-quality tagatose for use in a wide range of food and beverage products. Tagatose is 90% as sweet as table …

Indivior PLC  announced that it has completed the acquisition of Opiant Pharmaceuticals, Inc. (“Opiant”). The transaction strengthens Indivior’s addiction treatment and science portfolio by adding Opiant’s late-stage assets, notably OPNT003, an investigational opioid overdose treatment designed to offer an important treatment option to address the current wave of US opioid overdoses from powerful synthetic opioids, …

AMPEL BioSolutions  announced a genomic precision medicine test for chronic kidney diseases, such as Lupus Nephritis, that could save lives by predicting kidney damage before it is irreversible and providing decision support for prophylactic therapies.  Genes that drive the inflammatory pathways characteristic of different stages of kidney damage are revealed in the peer-reviewed journal Frontiers …

SRI International, an independent nonprofit research institute, has been awarded a $4.95 million contract, with options to fund up to $21 million, from the National Institute of Allergy and Infectious Diseases (NIAID) to develop drugs to increase the nation’s therapeutic arsenal against new or existing viral pathogens. The funds are part of the US government’s …

Governor Glenn Youngkin announced more than $66 million in state grants for four projects within the Biotechnology, Life Sciences and Pharmaceutical Manufacturing Cluster. These projects provide job creation, wage expansion, and broader economic growth throughout the Commonwealth. “In order to make Virginia a leader in biotechnology, life sciences and pharmaceutical manufacturing, we have to accelerate …

CytoRecovery, Inc., a leader in marker free technologies for the enrichment, sorting, and recovery of live cells, announced that the National Science Foundation (NSF) has approved its application to receive a Phase II SBIR Research Grant. Titled “Bioelectrical Cell Enrichment, Sorting, and Recovery with On-Chip Sample Prep and Monitoring,” the grant will provide $952,558 in …